A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Trial details
- Registry ID
- NCT07218146
- Drugs studied
- Investigator's Choice of Therapy, ZL-1310
TrialRedline tracks 5 clinical trials sponsored by Zai Lab (Shanghai) Co., Ltd.: 2 Phase 3, 3 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)NCT07218146 | Investigator's Choice of Therapy, ZL-1310 | Recruiting | 2028-06-30Estimated |
| A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye DiseaseNCT07211776 | ZL-1109 (VRDN-003) | Active not recruiting | 2027-03-14Estimated |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With ImatinibNCT04633122 | Ripretinib, Sunitinib | Completed | 2022-07-20Actual |
| A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)NCT04282980 | DCC-2618 | Completed | 2021-02-26Actual |
| A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBCNCT04262804 | Chosen Chemotherapy (Capecitabine), Chosen Chemotherapy (Gemcitabine ), Chosen Chemotherapy (Vinorelbine ), Margetuximab and 1 more | Unknown | 2021-09-03Actual |
Names as written in the registry records.
NCT07211776 · Zai Lab (Shanghai) Co., Ltd.
Before: Estimated. After: Actual.
Before: 99 participants (planned). After: 108 participants (actual).
Before: Recruiting. After: Active not recruiting.
NCT07218146 · Zai Lab (Shanghai) Co., Ltd.
Before: 665 participants (planned). After: 480 participants (planned).
Before: 30 Nov 2028. After: 30 Jun 2028.
Before: Not yet recruiting. After: Recruiting.
NCT07211776 · Zai Lab (Shanghai) Co., Ltd.
Before: Not yet recruiting. After: Recruiting.